Anette Sommer
Head of Bioconjugates Research Lonza
Seminars
Tuesday 13th October 2026
Lonza’s GlycoConnect Technology for Best-in-Class ADCs: Emerging Clinical Insights
12:30 pm
- Exploring how Lonza’s GlycoConnect and HydraSpace technologies enable ADCs with best-in-class therapeutic potential
- Sharing clinical development insights on the rapidly expanding and advancing pipeline of Lonza’s GlycoConnect technology based partnered ADC assets
- Discussing technology expansion towards high-DAR and dual payload ADCs
